Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Obstructive Sleep Apnea Syndrome | Research article

Clinico-epidemiological characteristics of men and women with a new diagnosis of chronic obstructive pulmonary disease: a database (SIDIAP) study

Authors: Josep Montserrat-Capdevila, Josep Ramon Marsal, Marta Ortega, Maria Teresa Castañ-Abad, Miquel Alsedà, Ferran Barbé, Pere Godoy

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

The risk of developing Chronic Obstructive Pulmonary Disease (COPD), the associated comorbidities and response to bronchodilators might differ in men and women. The objective of this study was to determine the prevalence of COPD and the clinic-epidemiological characteristics of primary care patients with COPD according to gender.

Methods

This is a cross-sectional study using electronic healthcare records Catalonia (Spain), during the 01/01/2012–31/12/2017 period. Patients from the SIDIAP database (System for the Development of Research in Primary Care) were included (5,800,000 patients registered in 279 primary care health centres). Clinic-demographic characteristics, comorbidities and blood tests results were collected for each patient. Adjusted OR (ORa) with logistic regression methods were used to determine variables associated with men and women.

Results

From an initial sample of 800,899 people, 24,135 (3%) were considered COPD patients, and 22.9%were women. The most common risk factors in women were bronchiectasis (ORa = 20.5, SD = 19.5–21.6), age > 71 years (ORa = 18.8; SD = 17.3–20.5), cor pulmonale (ORa = 5.2; SD = 4.3–6.7) and lung cancer (ORa = 3.6, SD = 3.2–4.0). Men and women presented the same comorbidities, though the strength of association was different for each gender.

Conclusions

Patients suffering high comorbidity rates. Comorbidities are similar in men and women, although the strength of association varies according to gender. Women are more susceptible to the harmful effects of smoking and present a higher proportion of bronchiectasis and OSAS.
Literature
1.
go back to reference Anar C, Bicmen C, Yapicioglu S, et al. Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease. New Microbiol. 2010;33(2):117–27.PubMed Anar C, Bicmen C, Yapicioglu S, et al. Evaluation of clinical data and antibody response following influenza vaccination in patients with chronic obstructive pulmonary disease. New Microbiol. 2010;33(2):117–27.PubMed
2.
go back to reference Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–8.CrossRef Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax. 2009;64(10):863–8.CrossRef
3.
go back to reference Soriano JB, Ancochea J, Miravitlles M, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur Respir J. 2010;36(4):758–65.CrossRef Soriano JB, Ancochea J, Miravitlles M, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur Respir J. 2010;36(4):758–65.CrossRef
4.
go back to reference Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med. 2011;9(7). Atsou K, Chouaid C, Hejblum G. Variability of the chronic obstructive pulmonary disease key epidemiological data in Europe: systematic review. BMC Med. 2011;9(7).
5.
go back to reference Jaén A, Ferrer A, Ormaza I, et al. Prevalence of chronic bronchitis, asthma and airflow limitation in an urban-industrial area of Catalonia. Arch Bronconeumol. 1999;35(3):122–8.CrossRef Jaén A, Ferrer A, Ormaza I, et al. Prevalence of chronic bronchitis, asthma and airflow limitation in an urban-industrial area of Catalonia. Arch Bronconeumol. 1999;35(3):122–8.CrossRef
6.
go back to reference Montserrat-Capdevila J, Seminario MA, Godoy P, et al. Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors. Med Clin. 2018;18:1–7. Montserrat-Capdevila J, Seminario MA, Godoy P, et al. Prevalence of chronic obstructive pulmonary disease (COPD) not diagnosed in a population with cardiovascular risk factors. Med Clin. 2018;18:1–7.
7.
go back to reference Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043–7.CrossRef Shahab L, Jarvis MJ, Britton J, et al. Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax. 2006;61(12):1043–7.CrossRef
8.
go back to reference Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–62.CrossRef Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax. 2010;65(11):956–62.CrossRef
9.
go back to reference Lahousse L, Niemeijer MN, van den Berg ME, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J. 2015;36(27):1754–61.CrossRef Lahousse L, Niemeijer MN, van den Berg ME, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur Heart J. 2015;36(27):1754–61.CrossRef
10.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRef Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRef
11.
go back to reference Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:1145–54.PubMedPubMedCentral Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:1145–54.PubMedPubMedCentral
12.
go back to reference Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–14.CrossRef Ntritsos G, Franek J, Belbasis L, et al. Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2018;13:1507–14.CrossRef
13.
go back to reference Soler-Cataluña JJ, Martínez-García MÁ, Serra PC. Multidimensional impact of COPD exacerbations]. Arch Bronconeumol. 2010;46(Suppl 1):12–9.CrossRef Soler-Cataluña JJ, Martínez-García MÁ, Serra PC. Multidimensional impact of COPD exacerbations]. Arch Bronconeumol. 2010;46(Suppl 1):12–9.CrossRef
14.
go back to reference Bolíbar B, Fina Avilés F, et al. SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research. Med Clin (Barc). 2012;138(14):617–21.CrossRef Bolíbar B, Fina Avilés F, et al. SIDIAP database: electronic clinical records in primary care as a source of information for epidemiologic research. Med Clin (Barc). 2012;138(14):617–21.CrossRef
15.
go back to reference Barrecheguren M, Monteagudo M, Ferrer J, et al. Treatment patterns in COPD patients newly diagnosed in primary care: a population-based study. Respir Med. 2016;111:47–53.CrossRef Barrecheguren M, Monteagudo M, Ferrer J, et al. Treatment patterns in COPD patients newly diagnosed in primary care: a population-based study. Respir Med. 2016;111:47–53.CrossRef
16.
go back to reference Jaén Díaz JI, de Castro Mesa C, Gontán García-Salamanca MJ, et al. Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers. Arch Bronconeumol. 2003;39(12):554–8.CrossRef Jaén Díaz JI, de Castro Mesa C, Gontán García-Salamanca MJ, et al. Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers. Arch Bronconeumol. 2003;39(12):554–8.CrossRef
17.
go back to reference Mirza S, Clay RD, Koslow MA, et al. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–502.CrossRef Mirza S, Clay RD, Koslow MA, et al. COPD guidelines: a review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–502.CrossRef
18.
go back to reference Brotons B, Pérez JA, Sánchez-Toril F, et al. The prevalence of chronic obstructive pulmonary disease and asthma: a cross-sectional study. Arch Bronconeumol. 1994;30(3):149–52.CrossRef Brotons B, Pérez JA, Sánchez-Toril F, et al. The prevalence of chronic obstructive pulmonary disease and asthma: a cross-sectional study. Arch Bronconeumol. 1994;30(3):149–52.CrossRef
19.
go back to reference Ramsey SD, Hobbs FDR. Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. Proc Am Thorac Soc. 2006;3(7):635–40.CrossRef Ramsey SD, Hobbs FDR. Chronic obstructive pulmonary disease, risk factors, and outcome trials: comparisons with cardiovascular disease. Proc Am Thorac Soc. 2006;3(7):635–40.CrossRef
20.
go back to reference Souverein PC, Berard A, Van Staa TP, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. 2004;90(8):859–65.CrossRef Souverein PC, Berard A, Van Staa TP, et al. Use of oral glucocorticoids and risk of cardiovascular and cerebrovascular disease in a population based case-control study. Heart. 2004;90(8):859–65.CrossRef
21.
go back to reference Comeche Casanova L, Echave-Sustaeta JM, García Luján R, et al. Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables. Arch Bronconeumol. 2013;49(9):383–7.CrossRef Comeche Casanova L, Echave-Sustaeta JM, García Luján R, et al. Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables. Arch Bronconeumol. 2013;49(9):383–7.CrossRef
22.
go back to reference John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest. 2005;127(3):825–9.CrossRef John M, Hoernig S, Doehner W, et al. Anemia and inflammation in COPD. Chest. 2005;127(3):825–9.CrossRef
23.
go back to reference Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923–9.CrossRef Cote C, Zilberberg MD, Mody SH, et al. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J. 2007;29(5):923–9.CrossRef
24.
go back to reference Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23.CrossRef Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352(10):1011–23.CrossRef
25.
go back to reference Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008;177(7):743–51.CrossRef Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med. 2008;177(7):743–51.CrossRef
26.
go back to reference Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–61.CrossRef Divo M, Cote C, de Torres JP, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–61.CrossRef
27.
go back to reference Olveira C, Padilla A, Martínez-García M-Á, et al. Etiology of bronchiectasis in a cohort of 2047 patients. an analysis of the spanish historical bronchiectasis registry. Arch Bronconeumol. 2017;53(7):366–74. Olveira C, Padilla A, Martínez-García M-Á, et al. Etiology of bronchiectasis in a cohort of 2047 patients. an analysis of the spanish historical bronchiectasis registry. Arch Bronconeumol. 2017;53(7):366–74.
28.
go back to reference Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684–92.CrossRef Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684–92.CrossRef
29.
go back to reference Villar F, Mendez M. EPOC e insuficiencia cardiaca. Arch Bronconeumol. 2009;45(8):383–93.CrossRef Villar F, Mendez M. EPOC e insuficiencia cardiaca. Arch Bronconeumol. 2009;45(8):383–93.CrossRef
30.
go back to reference Au DH, Udris EM, Fan VS, Curtis JR, et al. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest. 2003;123(6):1964–9.CrossRef Au DH, Udris EM, Fan VS, Curtis JR, et al. Risk of mortality and heart failure exacerbations associated with inhaled beta-adrenoceptor agonists among patients with known left ventricular systolic dysfunction. Chest. 2003;123(6):1964–9.CrossRef
31.
go back to reference Ezzati M, Kammen D. Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study. Lancet (London, England). 2001;358(9282):619–24.CrossRef Ezzati M, Kammen D. Indoor air pollution from biomass combustion and acute respiratory infections in Kenya: an exposure-response study. Lancet (London, England). 2001;358(9282):619–24.CrossRef
32.
go back to reference Chillón Martín MJ, Díez J de M, Moreno AF, et al. COPD and endocrine and metabolic alterations. Arch Bronconeumol. 2009;45 Suppl 4:42–6. Chillón Martín MJ, Díez J de M, Moreno AF, et al. COPD and endocrine and metabolic alterations. Arch Bronconeumol. 2009;45 Suppl 4:42–6.
Metadata
Title
Clinico-epidemiological characteristics of men and women with a new diagnosis of chronic obstructive pulmonary disease: a database (SIDIAP) study
Authors
Josep Montserrat-Capdevila
Josep Ramon Marsal
Marta Ortega
Maria Teresa Castañ-Abad
Miquel Alsedà
Ferran Barbé
Pere Godoy
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01392-y

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.